Altimmune, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 6, 2025 to Discuss Your Rights – ALT

(NasdaqGM:ALT), NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Altimmune, Inc. (“Altimmune” or the “Company”) (NASDAQ: ALT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Altimmune investors who were adversely affected by alleged securities fraud between August 10, 2023 […]

Levi & Korsinsky Reminds Lockheed Martin Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 26, 2025 – LMT

(NYSE:LMT), NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Lockheed Martin Corporation (“Lockheed Martin Corporation” or the “Company”) (NYSE: LMT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Lockheed Martin Corporation investors who were adversely affected by alleged securities

Dow Inc. Sued for Securities Law Violations – Contact Levi & Korsinsky Before October 28, 2025 to Discuss Your Rights – DOW

Dow Inc. Sued for Securities Law Violations – Contact Levi & Korsinsky Before October 28, 2025 to Discuss Your Rights – DOW GlobeNewswire September 25, 2025 NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Dow Inc. (“Dow Inc.” or the “Company”) (NYSE: DOW) of a class action securities

Levi & Korsinsky Reminds Unicycive Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 14, 2025 – UNCY

Levi & Korsinsky Reminds Unicycive Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 14, 2025 – UNCY GlobeNewswire September 25, 2025 NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Unicycive Therapeutics, Inc. (“Unicycive Therapeutics, Inc.” or the “Company”) (NASDAQ: UNCY)

Altimmune, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 6, 2025 to Discuss Your Rights – ALT

Altimmune, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 6, 2025 to Discuss Your Rights – ALT GlobeNewswire September 25, 2025 NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Altimmune, Inc. (“Altimmune” or the “Company”) (NASDAQ: ALT) of a class action securities lawsuit.

Levi & Korsinsky Reminds Lockheed Martin Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 26, 2025 – LMT

Levi & Korsinsky Reminds Lockheed Martin Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 26, 2025 – LMT GlobeNewswire September 25, 2025 NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Lockheed Martin Corporation (“Lockheed Martin Corporation” or the “Company”) (NYSE: LMT)

Levi & Korsinsky Reminds Fluor Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 14, 2025 – FLR

(NYSE:FLR), NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Fluor Corporation (“Fluor Corporation” or the “Company”) (NYSE: FLR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Fluor Corporation investors who were adversely affected by alleged securities fraud between February

Levi & Korsinsky Reminds Fluor Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 14, 2025 – FLR

Levi & Korsinsky Reminds Fluor Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 14, 2025 – FLR GlobeNewswire September 25, 2025 NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Fluor Corporation (“Fluor Corporation” or the “Company”) (NYSE: FLR) of a class

/C O R R E C T I O N — GreenLight Biosciences/

In the news release, GreenLight Biosciences Launches Norroa, the First RNA-Based Treatment for Varroa Mites, Offering New Hope Amid Record Bee Losses, issued 25-Sep-2025 by GreenLight Biosciences over PR Newswire, we are advised by the company that the media contact has been updated. The complete, corrected release follows: GreenLight Biosciences Launches Norroa, the First RNA-Based

PJM Membership Elects Two PJM Board Members

Robert Ethier and Le Xie Elected To Serve Three-Year Terms PJM Interconnection has announced today that its members have elected Robert Ethier and Le Xie to serve three-year terms on the PJM Board of Managers. https://mma.prnewswire.com/media/2782552/Bob_Ethier.jpg The process for electing Board members is set forth in the FERC-approved PJM Operating Agreement and is controlled by

Scroll to Top